Global Amebiasis Market Research Report 2023

Amebiasis Market

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Amebiasis market research.

The amebiasis drugs market is driven by the high burden of amebiasis infections, caused by the parasite Entamoeba histolytica, especially in developing regions with poor sanitation and healthcare facilities. Amebiasis can lead to severe gastrointestinal symptoms and potentially life-threatening complications. The increasing prevalence and severity of the disease have contributed to the demand for effective drugs to treat and manage amebiasis. Additionally, advancements in medical research and drug development have led to the introduction of new and improved therapies for better patient outcomes. However, challenges include the need for early diagnosis and proper management to prevent complications, potential drug resistance, and limited access to healthcare in some regions. Overcoming these challenges through increased awareness, affordable treatment options, and improved healthcare infrastructure will be crucial for the sustained growth of the amebiasis drugs market.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Amebiasis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Amebiasis Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Amebiasis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Metronidazole

1.2.3 Paromomycin

1.2.4 Tinidazole

1.2.5 Other

1.3 Market by Application

1.3.1 Global Amebiasis Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Pharmacy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Amebiasis Market Perspective (2018-2029)

2.2 Amebiasis Growth Trends by Region

2.2.1 Global Amebiasis Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Amebiasis Historic Market Size by Region (2018-2023)

2.2.3 Amebiasis Forecasted Market Size by Region (2024-2029)

2.3 Amebiasis Market Dynamics

2.3.1 Amebiasis Industry Trends

2.3.2 Amebiasis Market Drivers

2.3.3 Amebiasis Market Challenges

2.3.4 Amebiasis Market Restraints

3.1 Global Top Amebiasis Players by Revenue

3.1.1 Global Top Amebiasis Players by Revenue (2018-2023)

3.1.2 Global Amebiasis Revenue Market Share by Players (2018-2023)

3.2 Global Amebiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Amebiasis Revenue

3.4 Global Amebiasis Market Concentration Ratio

3.4.1 Global Amebiasis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Amebiasis Revenue in 2022

3.5 Amebiasis Key Players Head office and Area Served

3.6 Key Players Amebiasis Product Solution and Service

3.7 Date of Enter into Amebiasis Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Amebiasis Historic Market Size by Type (2018-2023)

4.2 Global Amebiasis Forecasted Market Size by Type (2024-2029)

5.1 Global Amebiasis Historic Market Size by Application (2018-2023)

5.2 Global Amebiasis Forecasted Market Size by Application (2024-2029)

6.1 North America Amebiasis Market Size (2018-2029)

6.2 North America Amebiasis Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Amebiasis Market Size by Country (2018-2023)

6.4 North America Amebiasis Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Amebiasis Market Size (2018-2029)

7.2 Europe Amebiasis Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Amebiasis Market Size by Country (2018-2023)

7.4 Europe Amebiasis Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Amebiasis Market Size (2018-2029)

8.2 Asia-Pacific Amebiasis Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Amebiasis Market Size by Region (2018-2023)

8.4 Asia-Pacific Amebiasis Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Amebiasis Market Size (2018-2029)

9.2 Latin America Amebiasis Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Amebiasis Market Size by Country (2018-2023)

9.4 Latin America Amebiasis Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Amebiasis Market Size (2018-2029)

10.2 Middle East & Africa Amebiasis Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Amebiasis Market Size by Country (2018-2023)

10.4 Middle East & Africa Amebiasis Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Dr. Reddy’s Laboratories

11.1.1 Dr. Reddy’s Laboratories Company Detail

11.1.2 Dr. Reddy’s Laboratories Business Overview

11.1.3 Dr. Reddy’s Laboratories Amebiasis Introduction

11.1.4 Dr. Reddy’s Laboratories Revenue in Amebiasis Business (2018-2023)

11.1.5 Dr. Reddy’s Laboratories Recent Development

11.2 Mission Pharmacal

11.2.1 Mission Pharmacal Company Detail

11.2.2 Mission Pharmacal Business Overview

11.2.3 Mission Pharmacal Amebiasis Introduction

11.2.4 Mission Pharmacal Revenue in Amebiasis Business (2018-2023)

11.2.5 Mission Pharmacal Recent Development

11.3 Aceto Corporation

11.3.1 Aceto Corporation Company Detail

11.3.2 Aceto Corporation Business Overview

11.3.3 Aceto Corporation Amebiasis Introduction

11.3.4 Aceto Corporation Revenue in Amebiasis Business (2018-2023)

11.3.5 Aceto Corporation Recent Development

11.4 Mylan Pharmaceuticals

11.4.1 Mylan Pharmaceuticals Company Detail

11.4.2 Mylan Pharmaceuticals Business Overview

11.4.3 Mylan Pharmaceuticals Amebiasis Introduction

11.4.4 Mylan Pharmaceuticals Revenue in Amebiasis Business (2018-2023)

11.4.5 Mylan Pharmaceuticals Recent Development

11.5 Impax Laboratories

11.5.1 Impax Laboratories Company Detail

11.5.2 Impax Laboratories Business Overview

11.5.3 Impax Laboratories Amebiasis Introduction

11.5.4 Impax Laboratories Revenue in Amebiasis Business (2018-2023)

11.5.5 Impax Laboratories Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Detail

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Amebiasis Introduction

11.6.4 Pfizer Revenue in Amebiasis Business (2018-2023)

11.6.5 Pfizer Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Detail

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Amebiasis Introduction

11.7.4 Sanofi Revenue in Amebiasis Business (2018-2023)

11.7.5 Sanofi Recent Development

11.8 Lupin Pharmaceuticals

11.8.1 Lupin Pharmaceuticals Company Detail

11.8.2 Lupin Pharmaceuticals Business Overview

11.8.3 Lupin Pharmaceuticals Amebiasis Introduction

11.8.4 Lupin Pharmaceuticals Revenue in Amebiasis Business (2018-2023)

11.8.5 Lupin Pharmaceuticals Recent Development

11.9 Glenmark Pharmaceuticals

11.9.1 Glenmark Pharmaceuticals Company Detail

11.9.2 Glenmark Pharmaceuticals Business Overview

11.9.3 Glenmark Pharmaceuticals Amebiasis Introduction

11.9.4 Glenmark Pharmaceuticals Revenue in Amebiasis Business (2018-2023)

11.9.5 Glenmark Pharmaceuticals Recent Development

11.10 Sun Pharmaceutical

11.10.1 Sun Pharmaceutical Company Detail

11.10.2 Sun Pharmaceutical Business Overview

11.10.3 Sun Pharmaceutical Amebiasis Introduction

11.10.4 Sun Pharmaceutical Revenue in Amebiasis Business (2018-2023)

11.10.5 Sun Pharmaceutical Recent Development

11.11 Heritage Pharmaceuticals

11.11.1 Heritage Pharmaceuticals Company Detail

11.11.2 Heritage Pharmaceuticals Business Overview

11.11.3 Heritage Pharmaceuticals Amebiasis Introduction

11.11.4 Heritage Pharmaceuticals Revenue in Amebiasis Business (2018-2023)

11.11.5 Heritage Pharmaceuticals Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Amebiasis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Metronidazole

    Table 3. Key Players of Paromomycin

    Table 4. Key Players of Tinidazole

    Table 5. Key Players of Other

    Table 6. Global Amebiasis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Amebiasis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Amebiasis Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Amebiasis Market Share by Region (2018-2023)

    Table 10. Global Amebiasis Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Amebiasis Market Share by Region (2024-2029)

    Table 12. Amebiasis Market Trends

    Table 13. Amebiasis Market Drivers

    Table 14. Amebiasis Market Challenges

    Table 15. Amebiasis Market Restraints

    Table 16. Global Amebiasis Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Amebiasis Market Share by Players (2018-2023)

    Table 18. Global Top Amebiasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis as of 2022)

    Table 19. Ranking of Global Top Amebiasis Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Amebiasis Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Amebiasis Product Solution and Service

    Table 23. Date of Enter into Amebiasis Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Amebiasis Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Amebiasis Revenue Market Share by Type (2018-2023)

    Table 27. Global Amebiasis Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Amebiasis Revenue Market Share by Type (2024-2029)

    Table 29. Global Amebiasis Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Amebiasis Revenue Market Share by Application (2018-2023)

    Table 31. Global Amebiasis Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Amebiasis Revenue Market Share by Application (2024-2029)

    Table 33. North America Amebiasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Amebiasis Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Amebiasis Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Amebiasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Amebiasis Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Amebiasis Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Amebiasis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Amebiasis Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Amebiasis Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Amebiasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Amebiasis Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Amebiasis Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Amebiasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Amebiasis Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Amebiasis Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Dr. Reddy’s Laboratories Company Detail

    Table 49. Dr. Reddy’s Laboratories Business Overview

    Table 50. Dr. Reddy’s Laboratories Amebiasis Product

    Table 51. Dr. Reddy’s Laboratories Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 52. Dr. Reddy’s Laboratories Recent Development

    Table 53. Mission Pharmacal Company Detail

    Table 54. Mission Pharmacal Business Overview

    Table 55. Mission Pharmacal Amebiasis Product

    Table 56. Mission Pharmacal Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 57. Mission Pharmacal Recent Development

    Table 58. Aceto Corporation Company Detail

    Table 59. Aceto Corporation Business Overview

    Table 60. Aceto Corporation Amebiasis Product

    Table 61. Aceto Corporation Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 62. Aceto Corporation Recent Development

    Table 63. Mylan Pharmaceuticals Company Detail

    Table 64. Mylan Pharmaceuticals Business Overview

    Table 65. Mylan Pharmaceuticals Amebiasis Product

    Table 66. Mylan Pharmaceuticals Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 67. Mylan Pharmaceuticals Recent Development

    Table 68. Impax Laboratories Company Detail

    Table 69. Impax Laboratories Business Overview

    Table 70. Impax Laboratories Amebiasis Product

    Table 71. Impax Laboratories Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 72. Impax Laboratories Recent Development

    Table 73. Pfizer Company Detail

    Table 74. Pfizer Business Overview

    Table 75. Pfizer Amebiasis Product

    Table 76. Pfizer Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 77. Pfizer Recent Development

    Table 78. Sanofi Company Detail

    Table 79. Sanofi Business Overview

    Table 80. Sanofi Amebiasis Product

    Table 81. Sanofi Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 82. Sanofi Recent Development

    Table 83. Lupin Pharmaceuticals Company Detail

    Table 84. Lupin Pharmaceuticals Business Overview

    Table 85. Lupin Pharmaceuticals Amebiasis Product

    Table 86. Lupin Pharmaceuticals Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 87. Lupin Pharmaceuticals Recent Development

    Table 88. Glenmark Pharmaceuticals Company Detail

    Table 89. Glenmark Pharmaceuticals Business Overview

    Table 90. Glenmark Pharmaceuticals Amebiasis Product

    Table 91. Glenmark Pharmaceuticals Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 92. Glenmark Pharmaceuticals Recent Development

    Table 93. Sun Pharmaceutical Company Detail

    Table 94. Sun Pharmaceutical Business Overview

    Table 95. Sun Pharmaceutical Amebiasis Product

    Table 96. Sun Pharmaceutical Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 97. Sun Pharmaceutical Recent Development

    Table 98. Heritage Pharmaceuticals Company Detail

    Table 99. Heritage Pharmaceuticals Business Overview

    Table 100. Heritage Pharmaceuticals Amebiasis Product

    Table 101. Heritage Pharmaceuticals Revenue in Amebiasis Business (2018-2023) & (US$ Million)

    Table 102. Heritage Pharmaceuticals Recent Development

    Table 103. Research Programs/Design for This Report

    Table 104. Key Data Information from Secondary Sources

    Table 105. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Amebiasis Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Amebiasis Market Share by Type: 2022 VS 2029

    Figure 3. Metronidazole Features

    Figure 4. Paromomycin Features

    Figure 5. Tinidazole Features

    Figure 6. Other Features

    Figure 7. Global Amebiasis Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Amebiasis Market Share by Application: 2022 VS 2029

    Figure 9. Hospital Case Studies

    Figure 10. Pharmacy Case Studies

    Figure 11. Amebiasis Report Years Considered

    Figure 12. Global Amebiasis Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Amebiasis Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Amebiasis Market Share by Region: 2022 VS 2029

    Figure 15. Global Amebiasis Market Share by Players in 2022

    Figure 16. Global Top Amebiasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Amebiasis Revenue in 2022

    Figure 18. North America Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Amebiasis Market Share by Country (2018-2029)

    Figure 20. United States Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Amebiasis Market Share by Country (2018-2029)

    Figure 24. Germany Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Amebiasis Market Share by Region (2018-2029)

    Figure 32. China Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Amebiasis Market Share by Country (2018-2029)

    Figure 40. Mexico Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Amebiasis Market Share by Country (2018-2029)

    Figure 44. Turkey Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Amebiasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Dr. Reddy’s Laboratories Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 47. Mission Pharmacal Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 48. Aceto Corporation Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 49. Mylan Pharmaceuticals Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 50. Impax Laboratories Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 51. Pfizer Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 52. Sanofi Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 53. Lupin Pharmaceuticals Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 54. Glenmark Pharmaceuticals Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 55. Sun Pharmaceutical Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 56. Heritage Pharmaceuticals Revenue Growth Rate in Amebiasis Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed